Cochrane Abstracts
Anti‐vascular endothelial growth factor (anti‐VEGF) agents for neovascular age‐related macular degeneration (nAMD): a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor (anti‐VEGF) Agents for Neovascular Age‐related Macular Degeneration (nAMD): a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440880/all/Anti‐vascular_endothelial_growth_factor__anti‐VEGF__agents_for_neovascular_age‐related_macular_degeneration__nAMD_:_a_network_meta‐analysis.
Anti‐vascular endothelial growth factor (anti‐VEGF) agents for neovascular age‐related macular degeneration (nAMD): a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440880/all/Anti‐vascular_endothelial_growth_factor__anti‐VEGF__agents_for_neovascular_age‐related_macular_degeneration__nAMD_:_a_network_meta‐analysis. Accessed February 9, 2026.
Anti‐vascular endothelial growth factor (anti‐VEGF) agents for neovascular age‐related macular degeneration (nAMD): a network meta‐analysis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440880/all/Anti‐vascular_endothelial_growth_factor__anti‐VEGF__agents_for_neovascular_age‐related_macular_degeneration__nAMD_:_a_network_meta‐analysis
Anti‐vascular Endothelial Growth Factor (anti‐VEGF) Agents for Neovascular Age‐related Macular Degeneration (nAMD): a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440880/all/Anti‐vascular_endothelial_growth_factor__anti‐VEGF__agents_for_neovascular_age‐related_macular_degeneration__nAMD_:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor (anti‐VEGF) agents for neovascular age‐related macular degeneration (nAMD): a network meta‐analysis
ID - 440880
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440880/all/Anti‐vascular_endothelial_growth_factor__anti‐VEGF__agents_for_neovascular_age‐related_macular_degeneration__nAMD_:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
